ต้นทุนประสิทธิผลของการใช้ Trastuzumab ร่วมลำดับแรกในมะเร็งเต้านมระยะ

trastuzumab  Trastuzumab is a biologic therapy indicated for the treatment of human epidermal growth factor receptor 2 -positive breast cancer and trastuzumab A drug used alone or with other drugs to treat certain types of breast cancer, stomach cancer, and gastroesophageal junction cancer that are HER2

Possible Side Effects of Trastuzumab · Heart Problems · Infusion-Related Side Effects · Lung Problems · Low White Blood Cell Count (Leukopenia For women with HER2-positive metastatic breast cancer, trastuzumab may be given on its own or with other treatments Treatment with trastuzumab

In the DESTINY-Breast04 trial, trastuzumab deruxtecan showed superior activity over standard chemotherapy options in patients with HER2-low advanced breast Trastuzumab was developed by Genentech Inc as a recombinant humanized monoclonal antibody directed against the